A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.
Socié G, Vigouroux S, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Bron D, Gard P, Medeghri Z, Lehert P, Lai C, Corn T, Vernant JP.
Socié G, et al. Among authors: lehert p.
Blood. 2017 Feb 2;129(5):643-649. doi: 10.1182/blood-2016-09-738625. Epub 2016 Nov 29.
Blood. 2017.
PMID: 27899357
Free article.
Clinical Trial.